Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
基本信息
- 批准号:9257198
- 负责人:
- 金额:$ 57.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlveolarAlveolar MacrophagesAnatomyAnti-Inflammatory AgentsAnti-inflammatoryAntigensApoptosisBiologicalBronchoalveolar Lavage FluidCISH geneCell physiologyCellsCodeColorCommunicable DiseasesCytokine SignalingDevelopmentDistalElementsEncapsulatedEpithelial CellsExtracellular SpaceFamilyFoundationsGasesGene ExpressionGrowth FactorHomeostasisHumanImmuneImmune responseIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjection of therapeutic agentJanus kinaseLaboratoriesLipopolysaccharidesLiposomesLungLung InflammationLung Lavage FluidMaintenanceMembranePhenotypePhysiologicalProcessPropertyProteinsPulmonary InflammationRecombinantsRegulationRodentRoleSTAT proteinSchemeSignal TransductionSignaling ProteinSurfaceTestingTherapeuticTissuesToxinTranscriptional ActivationVesicleWorkassaultcigarette smokingcytokineexosomein vitro testingin vivoinsightintercellular communicationmacrophagemembermouse modelnovelnovel therapeutic interventionparacrinepublic health relevanceresponserestraintuptakevector
项目摘要
DESCRIPTION (provided by applicant): In order to preserve homeostasis and normal gas exchange function, the lung must restrain inflammatory responses to the continual assault posed by infections, antigens, and toxins. Host responses in the distal lung are dictated in large part by the cross-talk between alveolar epithelial cells (AECs), which comprise the alveolar surface, and alveolar macrophages (AMs), its resident immune cells. Little is known about mechanisms by which AMs control inflammatory responses of AECs. We have recently identified a novel form of intercellular communication in which AMs secrete suppressors of cytokine signaling (SOCS) 1 and 3 proteins within membrane-delimited vesicles that can be taken up by AECs to inhibit inflammatory signaling in response to cytokines in vitro and in vivo. AM secretion of SOCS can be "tuned" by certain bioactive molecules, including those elaborated by AECs. Furthermore, cigarette smoking reduces while adenoviral infection increases SOCS levels in lung lavage fluid, indicating that dysregulation of SOCS secretion is associated with the known alterations in inflammatory responses that characterize these conditions. This proposal seeks to better understand the fundamental mechanisms, biological consequences, and therapeutic ramifications of this novel form of AM-AEC cross-talk. Aim 1 will characterize mechanisms regulating the release of two distinct types of vesicles - microparticles and exosomes - and the secretion of SOCS proteins within them, in response to bioactive molecules as well as AEC-derived factors. Aim 2 will determine the mechanisms controlling uptake of these distinct SOCS-containing vesicles in AECs and the effects of transcellular SOCS delivery on cytokine signaling, inflammatory gene expression, proliferation, and apoptosis in the target cells. Aim 3 will characterize the operative mechanisms for and consequences of dysregulated SOCS secretion in mouse models of acute inflammation induced by cigarette smoking and adenoviral infection. In addition, the effects and therapeutic potential of synthetic liposomal vesicles loaded with recombinant SOCS proteins will be tested in vitro and in vivo. These studies will provide new insights into the regulation of lung inflammation and a foundation for a novel therapeutic approach to its control.
描述(由申请人提供):为了保持体内平衡和正常的气体交换功能,肺部必须抑制对感染、抗原和毒素持续攻击的炎症反应。远端肺部的宿主反应在很大程度上取决于肺部。肺泡上皮细胞(AEC)(包括肺泡表面)和肺泡巨噬细胞(AM)(其常驻免疫细胞)之间的串扰机制知之甚少。 AM 控制 AEC 的炎症反应。我们最近发现了一种新的细胞间通讯形式,其中 AM 会在膜界定的囊泡内分泌细胞因子信号传导抑制物 (SOCS) 1 和 3 蛋白,这些蛋白可以被 AEC 摄取以抑制炎症信号传导。 SOCS 的 AM 分泌可通过某些生物活性分子(包括 AEC 所产生的分子)“调节”。 此外,吸烟可减少腺病毒感染。增加肺灌洗液中的 SOCS 水平,表明 SOCS 分泌失调与已知的炎症反应变化有关,而炎症反应是这些疾病的特征。该提案旨在更好地了解这种新型 AM 的基本机制、生物学后果和治疗后果。 -AEC 串扰将表征调节两种不同类型囊泡(微粒和外泌体)的释放以及其中 SOCS 蛋白的分泌的机制,以响应生物活性分子和生物活性分子。 AEC 衍生因子将描述控制 AEC 中这些不同的含有 SOCS 的囊泡的摄取的机制,以及跨细胞 SOCS 递送对细胞因子信号传导、炎症决定的靶细胞中的基因表达、增殖和凋亡的影响。吸烟和腺病毒感染引起的急性炎症小鼠模型中 SOCS 分泌失调的作用机制和后果此外,合成脂质体的作用和治疗潜力。装载有重组 SOCS 蛋白的囊泡将在体外和体内进行测试,这些研究将为肺部炎症的调节提供新的见解,并为控制炎症的新治疗方法奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC L PETERS-GOLDEN其他文献
MARC L PETERS-GOLDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC L PETERS-GOLDEN', 18)}}的其他基金
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10352439 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10112297 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10561635 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
9900069 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
9103201 - 财政年份:2015
- 资助金额:
$ 57.78万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
8961063 - 财政年份:2015
- 资助金额:
$ 57.78万 - 项目类别:
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
8504174 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
8665457 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
7910714 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
8080237 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
相似国自然基金
基于“糖原合成-UDPG/P2Y14/STAT1-肺泡巨噬细胞M1型极化”途径探讨热炎宁合剂治疗急性肺损伤的作用机制
- 批准号:82374418
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
Galectin-1抑制肺泡巨噬细胞线粒体损伤介导的NLRP3活化减轻流感致急性肺损伤的机制研究
- 批准号:82300005
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SIRT5-线粒体代谢轴失调介导SORT1Hi肺泡巨噬细胞METs形成在围术期急性肺损伤中的作用及机制研究
- 批准号:82371292
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向HMGB1的WGA-siRNA纳米生物材料抑制肺泡巨噬细胞焦亡在烧伤脓毒症急性肺损伤的作用和分子机制
- 批准号:82372517
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SIRT5去丙二酰化修饰Tom20抑制肺泡巨噬细胞M1极化缓解脓毒症急性肺损伤的机制研究
- 批准号:82302434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection
HIV/SIV 感染期间 SARS-CoV-2 的发病机制
- 批准号:
10685195 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
PET Tracer for Imaging of Lung Inflammation
用于肺部炎症成像的 PET 示踪剂
- 批准号:
10682270 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别: